Tikun Olam-Cannbit

Tikun Olam-Cannbit Pharmaceuticals, a manufacturer and distributor of cannabis products, will supply CBD-rich oil derived from the Cannbit strain as part of its patented SCI-210 treatment, a combination of CBD and CannAmide™. The SCI-210 treatment will be used in the company’s clinical trials targeting children with Autism Spectrum Disorder (ASD).